(S)-Methyl2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate , 98% , 113665-84-2
CAS NO.:113665-84-2
Empirical Formula: C16 H16 Cl N O2 S
Molecular Weight: 321.82
MDL number: MFCD05662337
EINECS: 601-269-2
Pack Size | Price | Stock | Quantity |
100mg | RMB104.00 | In Stock |
|
250mg | RMB166.40 | In Stock |
|
1g | RMB413.60 | In Stock |
|
5g | RMB1320.00 | In Stock |
|
others | Enquire |
PRODUCT Properties
alpha | D20 +51.52° (c = 1.61 in methanol) |
Boiling point: | 423.7±45.0 °C(Predicted) |
Density | 1.317±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: 50mg/ml in DMSO |
form | Oil |
pka | 4.56±0.20(Predicted) |
color | Colorless to light yellow |
InChI | InChI=1/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/s3 |
InChIKey | GKTWGGQPFAXNFI-UJHUVDBMNA-N |
SMILES | [C@@H](C1C=CC=CC=1Cl)(N1CCC2SC=CC=2C1)C(=O)OC |&1:0,r| |
CAS DataBase Reference | 113665-84-2(CAS DataBase Reference) |
Description and Uses
Clopidogrel was launched in the US as a potent inhibitor of platelet aggregation for the preventive management of secondary ischemic events, including MI, stroke and vascular deaths. Clopidogrel can be synthesized in 4 steps (including an optical resolution to the S active enantiomer) from 2-(2- ch1orophenyl)-glycine, the key step being the cyclization to thienopyridine with formaldehyde and acetic acid. Clopidogrel belongs to the original chemical class of Ticlopidine, but shows fewer side effects (in particular, bone-marrowsuppressing effects) at the dosage generally used. Like Ticlopidine, it is an Adenosine diphosphate (ADP) antagonist acting at the purinergic P2y receptor. In in vivo experiments with rabbits, Clopidogrel shows a maximal antiaggregant effect at 20mg/kg po, reducing adhesion of platelets to the vascular subendothelium ; moreover, it reduces myointimal thickening occuring after endothelial injury of rat carotid artery. Clopigrel does not affect platelet aggregation in vitro ; actually, its in vivo activity is highly dependent on hepatic metabolism. The results of a CAPRIE trial (Clopidogrel versus Aspirin in patients at risk of ischemic events) demonstrated that Clopidogrel was well tolerated and more effective than aspirin.
Sertraline metabolite
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
Hazard Codes | Xn |
Risk Statements | 22-36/37/38 |
Safety Statements | 26-36 |
Hazardous Substances Data | 113665-84-2(Hazardous Substances Data) |